Skip to main content Skip to footer content

Click to search

Staff resources
Contact us

Search...

Share your feedback

Menu

Home
About us
Our research
News and events
Patients and the public
Industry and partners
Staff resources
Training
Research inclusion

Home
About us
Our research
News and events
Patients and the public
Industry and partners
Staff resources
Training
Research inclusion

Home » News » Inflammatory liver disease

News

Filters

Search news
Search news
Article type
- Blog(8)
- News(120)
Research theme
- Cancer inflammation(6)
- Data, diagnostics and decision tools(21)
- Infection and acute care(5)
- Inflammatory arthritis(14)
- Inflammatory liver disease(16)
- Next generation therapies(1)
- Oral, intestinal and systemic health(8)
- Patient-reported outcomes(14)
- Sarcopenia and multimorbidity(6)
- Thrombo-inflammation(15)
- Women's metabolic health(10)
Key areas
- Equity and inclusion(17)
- Industry(6)
- Patient and public involvement(10)
- Training(4)
Date range
- From Date range
- To Date range

This past week

Most read articles

Blog
04 July 2023
Muscle Matters: Cracking the Code of Sarcopenia Sarcopenia and multimorbidity
News
28 August 2025
Adding cell-based vaccine to liver cancer therapy slows cancer progression in patients Inflammatory liver disease
News
13 July 2023
ExaLT trial reaches recruitment milestone Inflammatory liver disease

Array

28 August 2025

Adding cell-based vaccine to liver cancer therapy slows cancer progression in patients Inflammatory liver disease

17 March 2025

Pathways to better treatments for autoimmune liver diseases unveiled Inflammatory liver disease Back to top

10 February 2025

Common antibiotic could treat inflammatory bowel disease, new study finds Inflammatory liver disease Back to top

19 July 2024

First patient treated in cutting-edge rare liver disease clinical trial Inflammatory liver disease Oral, intestinal and systemic health Back to top

21 May 2024

Innovative organ-on-a-chip technology could shed light on cell behaviour in liver cancer Inflammatory liver disease Next generation therapies Back to top

17 May 2024

New stromal cell treatment for chronic inflammatory diseases being trialled Inflammatory liver disease Industry Back to top

10 May 2024

Birmingham study explores potential target to treat liver disease Inflammatory liver disease Back to top

19 April 2024

Bridging science and creativity: a reflective session on liver health Inflammatory liver disease Patient and public involvement Back to top

5 February 2024

New research into autoimmune liver condition suggests unique cell movements may be driving disease Inflammatory liver disease Back to top

30 November 2023

A milestone achievement: 3,000 patients have joined the NAFLD BioResource Inflammatory liver disease Back to top

7 November 2023

Promising target for liver disease treatments identified Inflammatory liver disease Back to top

30 October 2023

New inflammatory mechanisms unveiled in the setting of liver disease and liver cancer Inflammatory liver disease Back to top

Contact us

NIHR Birmingham Biomedical Research Centre
Institute of Translational Medicine
Birmingham
B15 2TH

birminghamBRC@uhb.nhs.uk

Quick links

About us
Events
Our partners
Privacy
Cookies
Accessibility

Follow us on

BirminghamBRC
LinkedIn

The NIHR Birmingham Biomedical Research Centre (BRC) is part of the NIHR and hosted by University Hospitals Birmingham NHS Foundation Trust (UHBFT) in partnership with the University of Birmingham (UoB).

Copyright © Designed by:
NHS Midlands and Lancashire Commissioning Support Unit
NHS Arden and Greater East Midlands Commissioning Support Unit

Back to top

Cookies on the NIHR website. We’ve put some small files called cookies on your device to make our site work. We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site. Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose. Alternatively, you can change your preferences.